135 Millennium - Twenty-first Edition MEDICINE, HEALTH CARE AND WELLNESS for the Genesis Behavior Center with a goal of expanding innovative options for care to all. As chief executive officer, Dr. Kiryakous remains active in all aspects of the company, overseeing daily operations in addition to longrange planning and research. She is proud to work alongside her daughter Jennifer, who handles the company’s financial functions, and looks forward to her other daughter, a doctoral candidate in psychology, joining in the coming years. Dr. Kiryakous considers the positive impact that her work has had on children and their families to be her professional legacy, and she hopes to continue her research into complementary TMS therapies for autism, believing it to be a core part of increasing baseline functional response to treatment. analytic tools for an eventual public launch. She considers the creation of this software to be one of her greatest professional accomplishments and the core of her philosophy of using datadriven treatment modalities to manage autism spectrum symptoms. In addition to ABA, Dr. Kiryakous has seen her patients achieve further success with combination therapies, including transcranial magnetic stimulation treatments. She created PrTMS Therapy in 2023 to further explore the potential of what she has termed “personalized repetitive transcranial magnetic stimulation therapy” in boosting the success of other established therapies for autism and increasing the longterm success of interventions. As of 2024, Dr. Kiryakous is exploring franchising opportunities
RkJQdWJsaXNoZXIy MTQ5NDA2